Teva Pharmaceutical Industries (TEVJF) Acquisitions (2022 - 2024)

Teva Pharmaceutical Industries (TEVJF) recorded quarterly Acquisitions of $15.0 million in Q1 2024, up 114.29% on a QoQ basis from $7.0 million in Q1 2022.

Teva Pharmaceutical Industries (TEVJF) Acquisitions (2022 - 2024) Analysis & Trends

Teva Pharmaceutical Industries has disclosed Acquisitions across 2 years of filings, most recently posting $15.0 million for Q1 2024.

  • Quarterly Acquisitions changed N/A year-over-year to $15.0 million in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $15.0 million (changed N/A YoY) and the FY2024 annual result came in at $15.0 million, changed N/A from the prior year.
  • Acquisitions grew to $15.0 million in Q1 2024, from $7.0 million in the prior quarter.
  • Over five years, Acquisitions peaked at $15.0 million in Q1 2024 and troughed at $7.0 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.09 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 137.87 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Teva Pharmaceutical Industries - - 1.97 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2024 15.00 Mn
Mar 31, 2022 7.00 Mn